Manipal Health Enterprises share price
NSE: MANIPALHOSBSE: 544847Healthcare Services
Manipal Health Enterprises Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2026 · Issue price ₹590
Last close ₹643.25up ₹5.20 (0.82%)BSE ₹642.70
Share price at the NSE close on 28 Oct 2026. Previous close ₹638.05.
28 Oct: open ₹631.25, high ₹651.10, low ₹625.55
Range of traded prices from listing on 5 Aug 2026 to 28 Oct 2026
₹597.00Low, 23 Oct 2026₹815.00High, 28 Aug 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. Market capitalisation: how it is worked out
- ₹84,612 Cr
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No full year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No balance sheet
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonesince listing in Aug 2026
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 8,53,39966.0% delivered
About Manipal Health Enterprises
Manipal Health Enterprises Limited and its subsidiaries, together called Manipal Hospitals, run a pan-India network of multispecialty hospitals.12 Their care runs from outpatient consultations and emergency treatment to complex tertiary and quaternary procedures, the most specialised levels of hospital care.1 The network serves patients in metro and non-metro markets, mainly in Karnataka, Maharashtra and Goa, and eastern India.13
The company reports a single business segment, healthcare services.4 Its focus is 6 complex specialties it calls CONGO-R: cardiac sciences, oncology (cancer), neurosciences, gastro sciences, orthopaedics and renal (kidney) sciences.5 It also offers internal medicine, general surgery, obstetrics and gynaecology, paediatrics, critical care, pulmonology and ENT.5 As of 30 Jun 2026 Manipal Hospitals had more than 11,000 doctors and more than 24,700 employees.6
The network began in 1991 with Manipal Hospital, Old Airport Road, Bengaluru, and the company was incorporated on 15 Feb 2010.78 Manipal Hospitals added 5,548 beds through acquisitions between Mar 2021 and Mar 2026, among them Columbia Asia, Vikram Hospitals, AMRI and Medica Synergie.9 In Bengaluru it opened new hospitals on Kanakapura Road, with 267 licensed beds, in June 2025 and in Yelahanka, with 264, in November 2025.10
Its promoters include Manipal Global Health Services, Kangto Investments, part of the Temasek group, and Ranjan Ramdas Pai, who chairs the Manipal Education and Medical Group.111213 Entities associated with TPG and Novo Holdings are also shareholders.14
Manipal Health Enterprises key points
Results
- In the quarter to Jun 2026, Manipal Hospitals' revenue from operations rose 38.1% year on year to ₹3,091 crore and EBITDA (earnings before interest, tax, depreciation and amortisation) rose 26.4% to ₹749 crore, a margin (EBITDA as a share of revenue) of 24.2% against 26.5%.1516
- Manipal Hospitals' profit after tax was ₹243 crore (7.9% of revenue) against ₹254 crore (11.4%) a year earlier, excluding Sahyadri Hospitals. Excluding ₹89 crore of post-tax interest on non-convertible debentures (bonds not convertible into shares) raised to buy Sahyadri, adjusted profit after tax grew 30.9%.161718
- In the year to Mar 2026, consolidated revenue from operations rose 25.40% to ₹10,335.75 crore from ₹8,242.26 crore, while consolidated profit after tax fell 15.26% to ₹916.59 crore from ₹1,081.67 crore.19
- Consolidated EBITDA for the year to Mar 2026 was ₹2,644 crore against ₹2,165 crore a year earlier, an EBITDA margin of 25.6% against 26.3%.20
Market position
- As of 31 Mar 2026 Manipal Hospitals was the largest pan-India multispecialty hospital network by bed capacity and the second-largest hospital chain by number of hospitals.21
- Hospitals and licensed beds by metro city, Jun 20262223As of 31 Mar 2026 Manipal Hospitals was the only private hospital chain in India to lead all 3 by bed capacity, the company says.
Item quarter to Jun 2026 Bengaluru 12 hospitals, 2,579 beds Kolkata 5 hospitals, 1,513 beds Pune 9 hospitals, 1,284 beds
Revenue mix
- CONGO-R specialties made up 65.4% of gross inpatient revenue (from admitted patients, before deductions) in the quarter to Jun 2026, against 64.7% a year earlier. Oncology inpatient revenue grew 62% and orthopaedics 49%.2425
- Gross inpatient revenue by payer, year to Mar 202626
Item year to Mar 2026 Insurance and third-party administrators (TPA, firms handling insurance claims) 49.7% Cash 30.3% Government 13.8% Others 6.2%
Hospitals and beds
- As of 30 Jun 2026 Manipal Hospitals had 13,140 licensed beds across 49 hospitals in 13 states and 1 union territory.29
- Hospitals and licensed beds by region, Jun 202630
Item quarter to Jun 2026 Karnataka (3,285 beds run for other owners) 19 hospitals, 6,404 beds East India (500 beds run for other owners) 10 hospitals, 2,887 beds Maharashtra and Goa 13 hospitals, 2,291 beds Other states 7 hospitals, 1,558 beds - Manipal Hospitals' 50th hospital, at Electronic City in Bengaluru, opened in July 2026 with about 300 licensed beds.3132
- In the quarter to Jun 2026 Manipal Hospitals' inpatient volumes grew 38.8% and outpatient 26.0%, occupancy was 65.0% and the average stay 2.7 days. Revenue per occupied bed per day (ARPOB) averaged ₹71,500; excluding Sahyadri it was ₹77,200, up 8.7% on a year earlier.3334
Expansion and capital spending
- The company stated in its annual report for the year to Mar 2026 it plans to add about 483 licensed beds at existing hospitals (brownfield) and 1,943 in new hospitals (greenfield) by 2030.35
- On its earnings call of 21 Aug 2026, the company said it expects to spend about ₹4,000 crore on capital projects over 3 to 4 years as it adds 3,000 beds, including about ₹2,000 crore in the year to Mar 2027.36
- On its earnings call of 21 Aug 2026, the company said it expects Raipur, its next large new hospital, to open in the quarter to Mar 2027, followed by Juhu in Mumbai.3738
Debt
- In the year to Mar 2026 Manipal Hospitals' finance costs rose 68.9%, mainly on non-convertible debentures, and net debt including leases rose to 3.7 times EBITDA from 2.0 times.3940
- On its earnings call of 21 Aug 2026, the company said net debt excluding leases was about 2.8 times annualised EBITDA, and repaying debt with IPO money by Sep 2026 would cut it to about 0.9 times on the quarter to Jun 2026 figures.4142
Recent events
- On 17 Aug 2026 the company agreed to buy the business and assets of Kinder Women's Hospital, a 100-bed hospital in Whitefield, Bengaluru, for ₹130 crore; it expected completion within 90 days, subject to approvals. It plans to remodel it as a multispecialty hospital.4344
- Its shares were listed on NSE and BSE on 5 Aug 2026 after an initial public offering in which new shares raised ₹8,000 crore. The money is intended for repaying borrowings and accrued interest, buying a minority stake in Sahyadri Hospitals and general corporate purposes.4546
- On 3 Oct 2025 its subsidiary bought 78.71% of Sahyadri Hospitals (10 hospitals, 1,606 licensed beds) for ₹4,596.54 crore. It bought a further 9.84% on 1 Dec 2025 and agreed to buy another 9.84%, for a base ₹574.05 crore, by 1 Dec 2026.4748
Last updated
All 48 sources, each with its page
- 1. Annual report, 4 Sep 2026, page 82
- 2. Annual report, 4 Sep 2026, page 35
- 3. Annual report, 4 Sep 2026, page 40
- 4. Annual report, 4 Sep 2026, page 83
- 5. Annual report, 4 Sep 2026, page 84
- 6. Investor presentation, 20 Aug 2026, page 10
- 7. Annual report, 4 Sep 2026, page 42
- 8. Annual report, 4 Sep 2026, page 223
- 9. Annual report, 4 Sep 2026, page 83
- 10. Annual report, 4 Sep 2026, page 85
- 11. Annual report, 4 Sep 2026, page 125
- 12. Annual report, 4 Sep 2026, page 7
- 13. Annual report, 4 Sep 2026, page 22
- 14. Annual report, 4 Sep 2026, page 49
- 15. Investor presentation, 20 Aug 2026, page 2
- 16. Investor presentation, 20 Aug 2026, page 3
- 17. Investor presentation, 20 Aug 2026, page 2
- 18. Investor presentation, 20 Aug 2026, page 12
- 19. Annual report, 4 Sep 2026, page 67
- 20. Annual report, 4 Sep 2026, page 86
- 21. Annual report, 4 Sep 2026, page 82
- 22. Investor presentation, 20 Aug 2026, page 11
- 23. Annual report, 4 Sep 2026, page 125
- 24. Investor presentation, 20 Aug 2026, page 2
- 25. Investor presentation, 20 Aug 2026, page 16
- 26. Annual report, 4 Sep 2026, page 83
- 27. Investor presentation, 20 Aug 2026, page 20
- 28. Investor presentation, 20 Aug 2026, page 12
- 29. Investor presentation, 20 Aug 2026, page 10
- 30. Investor presentation, 20 Aug 2026, page 11
- 31. Annual report, 4 Sep 2026, page 67
- 32. Earnings call, 21 Aug 2026, page 5
- 33. Investor presentation, 20 Aug 2026, page 2
- 34. Investor presentation, 20 Aug 2026, page 12
- 35. Annual report, 4 Sep 2026, page 86
- 36. Earnings call, 21 Aug 2026, page 13
- 37. Earnings call, 21 Aug 2026, page 10
- 38. Earnings call, 21 Aug 2026, page 8
- 39. Annual report, 4 Sep 2026, page 86
- 40. Annual report, 4 Sep 2026, page 83
- 41. Earnings call, 21 Aug 2026, page 13
- 42. Investor presentation, 20 Aug 2026, page 14
- 43. Exchange filing, 18 Aug 2026, page 2
- 44. Earnings call, 21 Aug 2026, page 14
- 45. Annual report, 4 Sep 2026, page 68
- 46. Annual report, 4 Sep 2026, page 90
- 47. Annual report, 4 Sep 2026, page 85
- 48. Annual report, 4 Sep 2026, page 68
Results
Consolidated; ₹ crore; no annual accounts on record yet.Manipal Health Enterprises quarterly results
Quarter to Jun 2026
- Revenue
- ₹3,091 Cr
- Net profit
- ₹243 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 7.9%
| ₹ crore | Jun 2026 |
|---|---|
| Revenue | 3,091 |
| Net profit | 243 |
| Net margin | 7.9% |
Consolidated. The quarter to Jun 2026, the first on record. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the quarter to Jun 2026 the company reports one business segment, Healthcare Services, which carries all its revenue.
Mutual fund holdings
73 funds disclosed a holding for Sep 2026. What they did in Sep 2026, against each fund's month before. 1 more fund filed its first portfolio on record, holding it.All 73 funds holding Manipal Health Enterprises
- Bought for the first timeBought for the first time. Funds that held it at the month's end and had not held it in any month on record before.
- 1
- AddedAdded. Funds that held more shares than at the end of the month before.
- 6
- CutCut. Funds that held fewer shares than at the end of the month before.
- 27
- Held unchangedHeld unchanged. Funds that held the same number of shares as at the end of the month before.
- 38
| Fund | |||
|---|---|---|---|
 Invesco India Mid Cap FundInvesco Mutual Fund | 98,78,758 | 4.44% | ₹699.7 Cr |
| Invesco India Large & Mid Cap FundInvesco Mutual Fund | 35,89,646 | 2.09% | ₹254.3 Cr |
| Invesco India Small Cap FundInvesco Mutual Fund | 35,00,905 | 1.54% | ₹248.0 Cr |
 Kotak Flexi Cap FundKotak Mahindra Mutual Fund | 33,98,112 | 0.45% | ₹240.7 Cr |
 ICICI Prudential Multi Asset Allocation FundICICI Prudential Mutual Fund | 33,96,222 | 0.29% | ₹240.6 Cr |
 Mirae Asset Midcap FundMirae Asset Mutual Fund | 26,21,277 | 0.95% | ₹185.7 Cr |
| Kotak Mid Cap FundKotak Mahindra Mutual Fund | 25,01,755 | 0.27% | ₹177.2 Cr |
| Mirae Asset Focused FundMirae Asset Mutual Fund | 24,59,933 | 2.74% | ₹174.2 Cr |
| Mirae Asset Large & Midcap FundMirae Asset Mutual Fund | 20,14,985 | 0.33% | ₹142.7 Cr |
 Aditya Birla Sun Life Midcap FundAditya Birla Sun Life Mutual Fund | 16,91,775 | 1.83% | ₹119.8 Cr |
Portfolios disclosed for Sep 2026. Weight is the holding as a share of the fund's assets.
Manipal Health Enterprises competitors and peers
Hospital, 40 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Manipal Health Enterprises in market cap.Healthcare companies
Manipal Health Enterprises is not on the chart: it has no P/E or return on equity today
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Apollo Hospitals EnterpriseAPOLLOHOSP | 1,16,998 | 55.99 | 12.34 | +17.2% | +32.8% | 23.6% | 19.9% | 0.25% |
 Max Healthcare InstituteMAXHEALTH | 82,877 | 56.87 | 7.71 | +16.0% | +27.0% | 14.5% | 13.0% | 0.23% |
 Aster DM Quality CareASTERDM | 58,354 | 183.11 | – | +15.7% | +0.2% | 8.0% | 12.4% | 0.45% |
 Fortis HealthcareFORTIS | 57,339 | 54.72 | 5.79 | +17.5% | +20.7% | 11.1% | 12.7% | 0.13% |
 Narayana HrudayalayaNH | 35,213 | 43.15 | 7.76 | +57.8% | +3.9% | 20.0% | 13.1% | 0.26% |
 Global HealthMEDANTA | 34,497 | 62.02 | 8.71 | +21.3% | +4.1% | 15.1% | 14.2% | 0.04% |
 Krishna Institute of Medical SciencesKIMS | 29,594 | 144.71 | 13.17 | +30.9% | −46.2% | 9.3% | 8.7% | 0.00% |
 Dr. Agarwal's Health CareAGARWALEYE | 15,063 | 101.53 | 7.44 | – | – | 7.6% | 14.1% | 0.00% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Latest announcements
Routine notices left out.Manipal Health Enterprises announcements
Oct 2026
Sep 2026
29 Sep · Meeting
18 Sep · Updates
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on NSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume | Delivery |
|---|---|---|---|---|---|---|---|
| 27 Oct 2026 | 631.95 | 667.75 | 626.05 | 638.05 | 648.27 | 31,28,712 | 79.2% |
| 26 Oct 2026 | 606.05 | 629.00 | 598.50 | 623.70 | 612.40 | 4,09,832 | 41.6% |
| 23 Oct 2026 | 625.40 | 625.45 | 597.00 | 607.35 | 606.46 | 4,42,986 | 50.7% |
| 22 Oct 2026 | 627.55 | 628.50 | 616.45 | 625.40 | 622.87 | 3,17,049 | 53.5% |
| 21 Oct 2026 | 630.25 | 644.95 | 625.10 | 627.55 | 631.41 | 5,56,416 | 57.0% |
| 19 Oct 2026 | 642.40 | 644.65 | 625.20 | 630.05 | 630.87 | 5,33,440 | 55.3% |
| 16 Oct 2026 | 645.00 | 653.75 | 636.25 | 642.40 | 645.67 | 3,40,279 | 42.8% |
| 15 Oct 2026 | 653.00 | 656.00 | 638.10 | 641.70 | 645.30 | 4,91,495 | 40.5% |
| 14 Oct 2026 | 667.00 | 667.95 | 647.00 | 650.05 | 657.00 | 5,42,456 | 47.7% |
Prices in ₹ per share as traded, not adjusted.
Company details
- NSE symbol
- MANIPALHOS
- BSE code
- 544847
- ISIN
- INE459N01021
- Industry
- Healthcare Services
- Website
- www.manipalhospitals.com
- Registered office
- #98/2,, The Annexe, HAL Airport Road, Rustom Bagh, Bengaluru 560017, Karnataka
- Share registrar
- KFin Technologies Ltd
- Keeps the register of shareholders and handles transfers and dividend payments